David Lebwohl

Notable Intellia Therapeutics Insider Trades $350K In Company Stock

David Lebwohl, EVP And Chief Medical Officer at Intellia Therapeutics (NASDAQ:NTLA), made a large buy and sell of company shares on November 5, according to a new SEC filing.

EVP And Chief Medical Officer Of Intellia Therapeutics Trades $340K In Company Stock

David Lebwohl, EVP And Chief Medical Officer at Intellia Therapeutics (NASDAQ:NTLA), made a large buy and sell of company shares on October 14, according to a new SEC filing.